Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Healthcare Deals This Week: Novartis, LB, Lila Sciences No Photo Available

Yeji Jesse Lee

A handful of sizable deals made headlines this past week, including a rare public offering from the pharmaceutical industry and a pote... (more story)

$50B Rural Health Fund: A Primer No Photo Available

Dan McKay

The U.S. Centers for Medicare & Medicaid Services will use a newly created $50 billion rural health fund to entice states to take unhe... (more story)

For Cahill Atty, Rare Disease Pro Bono Work Is Personal No Photo Available

Mark Payne

John MacGregor of Cahill Gordon & Reindel LLP didn't have any experience in healthcare law before taking on a pro bono client that sup... (more story)